Clinical Utility Of Two Novel Genes That Can Identify Patients At Higher Risk For Early Breast Cancer Recurrence

AviaraDx, Inc., formerly known as Arcturus Bioscience, Inc., a leader in molecular cancer profiling, announced today that a study, conducted in collaboration with Mayo Clinic, demonstrated the clinical utility of two novel genes that can identify patients at higher risk…

Read More

Positive Phase II Results With Orally Active GnRH Receptor Antagonist In Endometriosis – Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced positive results of its ‘proof of concept’, safety, efficacy and dose-finding Phase II clinical trial using its proprietary, orally-active small molecule Gonadotropin-Releasing Hormone (GnRH) receptor antagonist (NBI-56418). The 3-month data comes from a…

Read More

New Research Identifies Specific Teenage And Young Adult Cancers And Points To Possible Causes

An analysis of new data by a leading cancer researcher has revealed specific cancers that are most likely to affect teenagers and young adults, and it points to infections, adolescent growth spurts, and hormones as being among the possible causes.…

Read More

Helping Mentally Retarded Children And Adolescents: Support From Families And Health Care Professionals Have Significant Impact

The costs associated with mental retardation (MR) for persons born in 2000 will total over 51 billion dollars. While direct health and educational costs are significant, lifetime indirect costs due to productivity losses are much greater. Better efforts to understand…

Read More